Cooper Companies Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Hi, everyone. Sorry for the technical difficulties. This is Steve Lichtman, medical devices analyst at Oppenheimer. Welcome to the 31st Annual Oppenheimer Healthcare Conference. I'm very happy to have with us up next CooperCompanies. With us today is Dan McBride, Executive Vice President, COO and President of CooperVision; and Kim Duncan, Vice President, Investor Relations and Risk Management.
We're going to do this in a fireside format. If you have any questions, please key them in, and I will get them over to Dan and Kim. But with that, thank you both for joining us today.
Questions & Answers
Dan, I thought maybe we could talk a little bit to start off about the underlying contact lens market dynamics. You guys have pegged the market pretty consistently at a mid-single-digit level. There's multiple drivers. And I'm wondering if you can talk about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |